Immune Response for Patients With Metastatic Breast Cancer Treated by Everolimus
Clinical trial NCT02854618 · UNKNOWN
Trial details
- NCT number
- NCT02854618
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-26
- Primary completion
- 2022-05-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.